Cancer patient care program ranks among the nation’s top 50 ... Read More »
Our cancer program is among the nation’s finest, earning the Outstanding Achievement Award for exceptional quality from the American College of Surgeons Commission on Cancer. Our innovative multidisciplinary approach brings together many specialists focused on providing you the very best care.
Learn more about our appearance center.
Living well after breast cancer
Be part of the cure
Find us on Facebook
Improving Care Today - Making a Difference Tomorrow
Transforming Clinical Care
Stories of Hope and Courage
Working Toward a World without Cancer
Clinical trials can give you access to potentially effective new drugs, therapies and diagnostic tools in research. If you meet the criteria for a trial, you can decide if you would like to participate. By doing so, you have the potential to help yourself and others too.
Can a Trial Help Me?
This pilot phase 2 clinical trial evaluates the preliminary overall response rate of auranofin in patients with relapsed chronic lymphocytic leukemia, small lymphocytic lymphoma and prolymphocytic lymphoma. Read More »
This phase 2 clinical trial evaluates the response rates for patients with ovarian, non-small cell lung, prostate, colorectal, gastroesophagel and squamous cell carcinoma of the head and neck who receive the drug LY2523355. Read More »
This phase 1 clinical trial evaluates the investigational drug BKM120, used in combination with irinotecan, on KRAS wild-type or KRAS mutant types of colon cancer. Read More »
Central to The University of Kansas Cancer Center's vision of eliminating the cancer burden in the heartland is achieving designation... Read More »
This year, more than 13,000 Kansans will receive a cancer diagnosis. They will join more than 200,000 Kansas adults who are already living with the disease, including Micki Scherling of Goodland — a three-time breast cancer survivor.
It sounds like science fiction: high-energy radiation therapy kills cancerous tumors of the lung, breast, head and neck, spine, liver and abdomen in record time. But at The University of Kansas Cancer Center, TrueBeam™ and GammaPod are not science fiction at all.